newsfilter
← Latest News
GlobeNewswire·

NeuroMetrix Announces Strategic Launch of Quell Fibromyalgia

WOBURN, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the strategic launch of its Quell® Fibromyalgia device through the Pathfinder Program. Quell Fibromyalgia is the